IL-1α gene polymorphism in pulmonary sarcoidosis in relation to disease severity

B. Hutyrova, V. Kolek, R. M. du Bois, M. Petrek (Olomouc, Czech Republic; London, United Kingdom)

Source: Annual Congress 2002 - Interstitial lung disorders: markers of disease activity and severity
Session: Interstitial lung disorders: markers of disease activity and severity
Session type: Oral Presentation
Number: 1115
Disease area: Interstitial lung diseases

Congress or journal article abstract

Abstract

In the previous report we have demonstrated the association of IL-1 alpha -889 single nucleotide polymorphism with sarcoidosis in Czech population. We have, therefore, performed a pilot study to investigate if there was any relationship between this polymorphism and severity of pulmonary sarcoidosis as assessed by pulmonary function tests. In 67 patients with pulmonary sarcoidosis the pulmonary functions at presentation were evaluated by testing the following parameters: FEV1, FVC, FEV1/FVC, TLC, and DLco. Genotyping of IL-1 alpha -889 polymorphism in each patient was performed by PCR with sequence specific primers. The differences in pulmonary function data were tested by Mann-Whitney U test. In the group of sarcoidosis patients the lung function parameters were compared between carriers and non-carriers of the IL-1 alpha -889 allele 2 (genotypes 1.2 and 2.2 vs genotype 1.1). No statistically significant difference could be found between subjects with different genotypes. Based on the results of this pilot study, we conclude that although the IL-1 alpha -889 polymorphism is associated with susceptibility to sarcoidosis, this polymorphism is not related to the disease severity in Czech patients with sarcoidosis.
Grant support: GACR 310/99/1676 and MSM.15110002.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Hutyrova, V. Kolek, R. M. du Bois, M. Petrek (Olomouc, Czech Republic; London, United Kingdom). IL-1α gene polymorphism in pulmonary sarcoidosis in relation to disease severity. Eur Respir J 2002; 20: Suppl. 38, 1115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiotensin-converting-enzyme gene polymorphism and susceptibility to chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 195s
Year: 2002

CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis
Source: Eur Respir J 2010; 35: 324-330
Year: 2010



VNTR polymorphism NOS3 gene among chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003

The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012


The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 315s
Year: 2004

A single nucleotide polymorphism in NOD2 gene was associated with pathogenesis and severity of COPD
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 148s
Year: 2006

Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression
Source: Eur Respir J 2008; 32: 1004-1008
Year: 2008



Polymorphism of collagen I gene and glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease associated with cardiovascular disease
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008



Cryptogenic pulmonary fibrosis and gene polymorphism
Source: Annual Congress 2007 - The role of gene polymorphisms in pulmonary disease susceptibility
Year: 2007


Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006


The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Association of the 3A/4A (134delA) and Lys198Asn polymorphisms of the endothelin-1 gene with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Relationship of the polymorphism Lys198Asn endothelin-1 gene with COPD and coronary heart disease.
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 373s
Year: 2007

IFNL3 polymorphisms are associated with COPD severity and outcomes
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017

Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015